Rubric Assessments (626384)
Assessment | Metrics | Date | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
MEMA MCF10A Staining Set 2 no H3 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
XMD11-85h KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
GCP aggregated data - CRISPR perturbations | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA MCF10A Staining Set C | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - ATAC-seq | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by Reverse Phase Protein Arrays (RPPA) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (December 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
PLX4032 KiNativ -- dose response experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA HMEC240L Staining Set 4 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
EGF and Insulin combination dose and dynamic response of ERK, AKT, and mTOR signaling and the cell cycle (Cyclin D1) in serum- and growth-factor starved MCF10A cells | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
GCP aggregated data - Chemical perturbations | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
L1000 Dataset -small molecule perturbagens- LINCS Phase 2 (June 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Proteomics dataset (March 2016) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA MCF7 Staining Set 1 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Torin2 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (March 2017) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA MCF7 Staining Set 3 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
NVP-BHG712 KiNativ -- multiple dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
JWE-035 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Breast Cancer Profiling Project - Proteomics 2: 1 phosphoproteome dataset (including phosphotyrosine enrichment) for a 35-cell line breast cancer panel under basal conditions | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
XMD16-144 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
XMD8-85 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
iPSC (Exp 1) - ALS, SMA and Control (unaffected) subject-derived iPSC lines - SWATH-MS | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Transcriptomics dataset (June 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
OTSSP167 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 |